Mechanistic insights into KRAS G12D inhibitor binding revealed by molecular dynamics simulations of multiple crystal structures
Physical Chemistry Chemical Physics · 2026
DOI: 10.1039/d5cp03384e ↗Kurz gefasst
Fachartikel in der Zeitschrift Physical Chemistry Chemical Physics, 2026. Verfasst von Donghwan Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Atomatrix, 851, Daewangpangyo-ro 815, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea. sblee@atomatrix.co.kr. Hauptthemen laut MEDLINE: Molecular Dynamics Simulation, Proto-Oncogene Proteins p21(ras). Die Arbeit nennt 53 Literaturangaben.
Abstract (Originalsprache)
The discovery of selective and potent KRAS G12D inhibitors remains a critical priority in oncology drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Atomatrix, 851, Daewangpangyo-ro 815, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea. sblee@atomatrix.co.kr.
Zitieren
APA
Kim, D., Lee, E., & Lee, S. (2026). Mechanistic insights into KRAS G12D inhibitor binding revealed by molecular dynamics simulations of multiple crystal structures. Physical Chemistry Chemical Physics. https://doi.org/10.1039/d5cp03384e
Vancouver
Kim D, Lee E, Lee S. Mechanistic insights into KRAS G12D inhibitor binding revealed by molecular dynamics simulations of multiple crystal structures. Physical Chemistry Chemical Physics. 2026. doi:10.1039/d5cp03384e
BibTeX
@article{Kim2026,
author = {Kim, Donghwan and Lee, Eunho and Lee, Sangbae},
title = {Mechanistic insights into KRAS G12D inhibitor binding revealed by molecular dynamics simulations of multiple crystal structures},
journal = {Physical Chemistry Chemical Physics},
year = {2026},
doi = {10.1039/d5cp03384e}
}
EUVIMED